Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura
Clinical trial NCT06291025 · RECRUITING
Trial details
- NCT number
- NCT06291025
- Sponsor
- University Hospital, Rouen
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-10
- Primary completion
- 2026-08-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.